PDM++ Explained: The Bipolar-Pulse Technology Exclusive to Glow
About the Authors
Bertica M. Rubio, M.D.
Medical Director, Antiaging Regenerative Medicine Clinic | Board-Certified Physician | Dartmouth Medical School
Dr. Bertica M. Rubio is a board-certified physician and Medical Director of the Antiaging Regenerative Medicine Clinic in Redlands, California. She earned her Bachelor of Science degree from Loyola Marymount University and her Doctor of Medicine from Dartmouth Medical School (Geisel School of Medicine). She completed her pediatrics residency at UC Irvine Medical Center.
With decades of clinical experience, Dr. Rubio specializes in age management medicine, regenerative medicine, wound healing, and growth factor therapies. Her practice integrates evidence-based medical science with advanced aesthetic and regenerative treatments, helping patients achieve optimal health and youthful vitality.
Dr. Rubio is passionate about educating patients on the science behind skincare, facial rejuvenation, and non-invasive technologies like EMS (Electrical Muscle Stimulation) for facial toning. Her articles for PureLift LAB combine rigorous medical knowledge with practical guidance for achieving real, lasting results.
Andrew Conrad Barile, PT, DPT
Doctorate of Physical Therapy (DPT), Licensed Physical Therapist (PT)
Dr. Andrew Conrad Barile is a Doctor of Physical Therapy and the CEO and Founder of Xtreem Pulse LLC. He earned his Doctorate in Physical Therapy from Daemen College and brings over two decades of clinical and entrepreneurial experience in pediatric physical therapy, craniosacral therapy, and medical device innovation. His deep understanding of human anatomy, muscle physiology, and therapeutic technology provides invaluable science-backed approach to facial rejuvenation and anti-aging solutions.
Daniel Grinberg, MD, FACS
Board-Certified Otolaryngologist & Head and Neck Surgeon | Fellow, American College of Surgeons | Assistant Clinical Professor, Mount Sinai School of Medicine
Daniel Grinberg, MD, FACS is a Board-Certified Otolaryngologist and Head & Neck Surgeon at ENT and Allergy Associates in West Nyack, NY. He earned his medical degree from Columbia University College of Physicians and Surgeons, completed his Otolaryngology residency at New York University Medical Center, and serves as Assistant Clinical Professor at Mount Sinai School of Medicine. He is a Fellow of both the American College of Surgeons and the American Academy of Otolaryngology.
Dr. Grinberg's head-and-neck surgical perspective brings PureLift LAB readers a wider clinical lens — connecting at-home EMS practice to the underlying medical anatomy with the same scientific rigor we apply to every device specification.
Prof. Dr. med. Ivo Buschmann
Chair of Angiology, Medizinische Hochschule Brandenburg | Clinic Director, University Clinic for Angiology, Brandenburg University Hospital | Former Senior Consultant, Charité Universitätsmedizin Berlin
Prof. Dr. med. Ivo Buschmann is Chair of Angiology at the Medizinische Hochschule Brandenburg Theodor Fontane (MHB) and Clinic Director of the University Clinic for Angiology at the Brandenburg University Hospital. He completed his medical training at the University of Hamburg, served as a Max-Planck Society Fellow at the Max-Planck-Institute for Heart and Lung Research, and held senior consultant positions at the Charité Universitätsmedizin Berlin Campus Virchow before being appointed Chair at MHB in 2016.
Prof. Buschmann is one of Europe's leading authorities on arteriogenesis — the flow-driven growth and remodeling of blood vessels — with more than 150 peer-reviewed publications and several US and EU patents on devices that stimulate collateral blood vessel growth through controlled shear-rate therapy. His research connects mechanical and electrical stimulation to vascular adaptation, microcirculation, and tissue perfusion.
Prof. Buschmann's contributions bring PureLift LAB readers a vascular-biology perspective that complements our existing clinical, physical-therapy, and surgical-anatomy authorship — explaining how EMS stimulation engages not only facial muscles but also the microcirculation that supplies them, and why smart delivery matters at the level of blood flow as much as muscle contraction.
Share
PDM++ is the bipolar-pulse evolution of PureLift's core PDM™ technology, and it is exclusive to PureLift Glow. That definition is precise and intentionally limited. PDM++ changes the pulse architecture within Glow, but the supplied evidence does not establish that it reaches deeper, recruits more motor units, feels more comfortable, or produces better cosmetic outcomes than standard PDM™. Understanding the feature starts by separating what the engineering specification confirms from conclusions that would require direct comparative testing.
Start with the PDM foundation
PDM™ is the waveform-delivery architecture shared by all five PureLift models. It consists of two trademarked parts. Dynamic Modulation™ continuously varies operation through the 1,370 to 1,730 Hz band and cycles through 361 distinct frequencies. Triple-Wave™ layers three simultaneous waveform components: a low-frequency component for surface anaesthetic effect, a mid-frequency component for the dermal layer, and a high-frequency component for deep muscle reach. Describing PDM™ as only a changing frequency omits half of the architecture, while describing Triple-Wave™ as pulse-width, amplitude, and frequency modulation is incorrect.
The general scientific support applies to varied or modulated stimulation compared with constant-frequency stimulation. PureLift's particular 361-frequency implementation is an engineering design choice. It is reasonable to explain its purpose as reducing accommodation relative to a fixed-frequency signal, but it is not accurate to promise that adaptation is completely prevented or that every contraction remains identical throughout a session.
What bipolar pulse means here
PDM++ adds a bipolar-pulse evolution to that shared PDM™ foundation. In plain language, bipolar describes polarity behavior in the pulse architecture. It does not mean that Glow contains two unrelated stimulation systems, doubles the number of frequencies, or replaces Dynamic Modulation™ and Triple-Wave™. PDM++ belongs within Glow's electrical design while the underlying PDM™ architecture remains present.
The verified distinction is therefore architectural. Glow includes PDM++, while Face, Pro, Pro Edition, and Pro Plus use PDM™ without the Glow-exclusive bipolar-pulse evolution. This allows a factual model comparison without inventing a physiological result. A different pulse design can be a meaningful engineering feature even when no head-to-head trial has established a superior visible outcome.
What the evidence does not establish
No supplied randomized controlled trial compares Glow's bipolar-pulse architecture with standard PDM™. No cited evidence shows that the bipolar-pulse design activates more facial muscle fibers, creates a more uniform current pattern, reaches a different depth, or improves one facial zone more consistently. Nor does supplied head-to-head evidence show that users tolerate a higher setting because of the design or experience a universally different sensation.
Those limits matter because electrical stimulation is affected by output, placement, contact, conductive medium, skin impedance, anatomy, and user-selected intensity. A claim about the independent effect of PDM++ would need a study that controls those variables. Without that comparison, the responsible statement is that PDM++ is Glow's exclusive bipolar-pulse engineering evolution, not that it guarantees broader recruitment or superior results.
Why an architecture label is not an outcome
Engineering descriptions explain how a system is built. Clinical and cosmetic claims explain what happens when people use it. The first does not automatically prove the second. Calling PDM++ a bipolar-pulse evolution accurately identifies an electrical-design difference. Saying that this difference creates a larger lift, a faster timeline, or a more complete facial response would cross into an outcome claim that needs direct evidence.
The same distinction protects comparisons within the PureLift line. Standard PDM™ is not an obsolete technology displaced by PDM++. It remains the complete architecture in Face, Pro, Pro Edition, and Pro Plus. Glow is the model that adds the fourth engineering pillar. Buyers can value that addition without being told that every other PureLift model delivers an inferior physiological response.
PDM++ and the Glow feature set
Glow should be evaluated as a complete device rather than as a single waveform label. It combines output up to 9 mA with PDM™, PDM++, Active plus Infuse operating modes, a diamond-faceted probe, and an OSRAM dual-wavelength LED system. Its red wavelength is 634 nm, and its blue wavelength is 465 nm, with a 464 nm peak. Combined irradiance is 1.13 W/m², and the stated fluence is 678 J/m² during a 10-minute session. Those optical measurements were characterized under the IEC 62471:2006 method with the sensor at 20 cm. They describe measured device output, not an at-skin clinical dose.
The cleared indications include facial and neck stimulation, wrinkle treatment, and mild to moderate inflammatory acne. Glow is not presented for severe or cystic acne, and the LED should never be used over the eyes or eyelids. These are concrete reasons to choose Glow. They do not require attributing an unverified outcome to PDM++.
How PDM++ relates to Next-Gen EMS
PureLift uses Next-Gen EMS as the category frame for its combination of real milliamp-range power and modulated kHz-band delivery. Standard first-generation EMS typically relies on a single fixed frequency. Microcurrent devices operate at much lower current and, according to the technical source, generally at 1 to 8 Hz. PureLift's range extends from low settings intended for surface-level cosmetic support to motor-level EMS at higher output, with Glow reaching up to 9 mA.
PDM++ is not the definition of Next-Gen EMS and should not be used to imply that the other PureLift models lack the category's core advantages. All five models run PDM™. Glow adds the bipolar-pulse evolution as one of its exclusive features. For a fuller explanation of why varied delivery is distinct from a fixed signal, see modulated versus fixed-frequency EMS.
The regulatory and manufacturing context
All five PureLift models are FDA-cleared 510(k) Class II devices. They are manufactured in Japan in facilities operating to ISO 9001 and ISO 13485 standards. Those facts apply to Glow without turning clearance into proof that PDM++ outperforms standard PDM™. Regulatory clearance, quality-system standards, and comparative efficacy are different questions and should be described separately.
The same discipline applies to published facial NMES research. Category-level studies can support discussion of electrical muscle stimulation and cosmetic appearance outcomes. They do not establish that Glow's proprietary PDM++ feature produces a larger result than another PureLift model. A proprietary engineering detail and an independently demonstrated clinical advantage are not interchangeable.
How to decide whether PDM++ matters to you
A buyer should not choose Glow because of an unsupported promise about recruitment, depth, comfort, or speed. The stronger rationale is that Glow assembles PureLift's most complete documented feature set in one device. PDM++ is part of that package, together with 9 mA maximum output, dual operating modes, the diamond-faceted probe, and red plus blue LED.
If the bipolar-pulse evolution and integrated LED are not priorities, another model may provide the PDM™ foundation at a lower price. If the goal is to own the full PureLift engineering and light feature set, Glow is the direct choice. The model decision should rest on documented capabilities rather than a claim that PDM++ alone has proved superior cosmetic performance.
Keep the model boundaries clear
PDM++ belongs only to Glow. Pro Plus includes the 9 mA maximum, diamond-faceted probe, and Active plus Infuse modes. Glow includes those same three features. PDM™, the 1,370 to 1,730 Hz band, Triple-Wave™, Japanese manufacture, and FDA-cleared Class II status apply across all five PureLift devices. Keeping those boundaries clear prevents a Glow-exclusive feature from being assigned to Pro Plus and prevents a shared feature from being used as a false reason to upgrade.
Using Glow accurately and consistently
A 10-minute session still depends on the fundamentals. Follow the device instructions, use an appropriate conductive medium for electrical stimulation, maintain contact, and select an intensity that fits the prescribed routine. Low settings should not be described as extra muscle work. The technical source is explicit that the lift comes from EMS at higher output, while lower-power use supports skin-focused benefits.
Consistency also does not justify predicting an identical timeline for every user. Facial anatomy, placement, selected intensity, technique, and routine adherence can affect the cosmetic experience. PDM++ does not remove those variables. It is a feature within the system, not a guarantee that individual outcomes will follow a fixed schedule.
The bottom line
PDM++ is the Glow-exclusive bipolar-pulse evolution of PDM™. That is the verified differentiator. It does not replace Dynamic Modulation™ or Triple-Wave™, and the supplied evidence does not prove better recruitment, greater depth, improved comfort, or superior cosmetic outcomes versus standard PDM™. Glow remains the clear choice for buyers who want PDM++ together with 9 mA output, Active plus Infuse modes, the diamond-faceted probe, and dual-wavelength LED. For a direct product decision, see the PureLift Pro Plus versus PureLift Glow comparison.